Post-COVID conditions (PCC) refer to a diverse array of symptoms that persist for weeks, months, and even years after acute SARS-CoV-2 infection and significantly impact quality of life.

Join us for a live, expert-led webinar exploring the evolving role of GPRC5D-targeted CAR T-cell therapies in multiple myeloma.

Bipolar disorder (BD) is a chronic and disabling mood disorder often complicated by overlapping symptoms, frequent misdiagnosis, poor adherence, and comorbidities, leaving significant gaps in care.

Longstanding barriers to care combined with an elevated risk of diabetic macular edema (DME) contribute to the disproportionate burden of DME in Native American communities.

Join us for a live webinar focused on the evolving role of immunotherapy in early-stage resectable non-small cell lung cancer (NSCLC).

Novel targeted therapies offer new hope to slow progression and improve quality of life in meaningful ways for patients with primary biliary cholangitis (PBC).

Platinum-resistant ovarian cancer (PROC) remains one of the most significant challenges in gynecologic oncology; however, novel antibody-drug conjugates (ADCs) and innovative investigational therapies are opening new avenues to improve outcomes.

Join us for a live webinar where expert faculty will provide actionable insights on improving patient identification and engagement for CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).

Embark on the path to become an expert injector! This program provides you with the knowledge and practical skills needed to succeed. Class size is limited to 8, ensuring you receive an individualized training environment. Models are provided.

Join us Dec 6–7 for a full weekend of hands-on procedural training! Master suturing, I&D, biopsies, splinting & nail procedures. Real materials, small groups, expert instruction, and lunch included.